Latest filing published 07 May 2024 for Twist Bioscience Corp, €28k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
William Banyai, listed as senior executive, appears in our data through filings on Twist Bioscience Corp shares, published by SEC (Form 4). Between 20 May 2021 and 3 May 2024, the trades on record add up to 57 filings.
Every open-market trade on record is a sale: 13 sales worth €2.1M. Besides market trades, the filings include 43 share grants and 1 option exercise. So far in 2024, the count stands at no purchases and 4 sales.
The newest entry dates from 7 May 2024: an open-market sale of €28k, in Twist Bioscience Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 57 declarations